Effect of vitamin D and calcium supplementation on bone turnover in institutionalized adults with Down's Syndrome

European Journal of Clinical Nutrition

Volumn 60, Issue 5, 2006, Pages 605-609

  Zubillaga, P ^a   Garrido, A ^a   Mugica, I ^a   Ansa, J ^a   Zabalza, R ^a   Emparanza, J I ^a  

^a Fundacion Uliazpi   (Spain)

Author keywords

Calcium; Down's syndrome; Oteoporosis; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; ANTICONVULSIVE AGENT; BIOCHEMICAL MARKER; CALCIUM; CALCIUM CARBONATE; CALCIUM LACTOGLUCONATE; CARBAMAZEPINE; COLECALCIFEROL; ESTROGEN; FLUORIDE; OSTEOCALCIN; PARATHYROID HORMONE; PHENOBARBITAL; PHENYTOIN; PHOSPHORUS; TESTOSTERONE; VITAMIN D; CALCIFEDIOL;

ADULT; ANOREXIA; ARTICLE; BLOOD ANALYSIS; BONE METABOLISM; BONE REMODELING; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN SYNDROME; DRUG DOSE REGIMEN; FEMALE; HUMAN; HYPERCALCEMIA; INSTITUTIONAL CARE; MALE; OPEN STUDY; PARALLEL DESIGN; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; RANDOMIZED CONTROLLED TRIAL; SPAIN; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; VOMITING; BLOOD; BONE; BONE DENSITY; CALCIUM INTAKE; DIET SUPPLEMENTATION; DRUG EFFECT; INSTITUTIONALIZATION; METABOLISM; OSTEOPOROSIS;

ADULT; BONE AND BONES; BONE DENSITY; CALCIFEDIOL; CALCIUM; CALCIUM, DIETARY; DIETARY SUPPLEMENTS; DOWN SYNDROME; FEMALE; HUMANS; INSTITUTIONALIZATION; MALE; OSTEOCALCIN; OSTEOPOROSIS; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 33744978813     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602357     Document Type: Article

References (33)

1. American Academy of Pediatrics Committee on Genetics (2001). Health supervision for children with Down syndrome. Pediatrics 107, 442-449.
2. Bullamore JR, Wilkinson R, Gallear JC, Nordin BEC, Marshall DH (1970). Effect of age on calcium absortion. Lancet 2, 535-537.
3. Center J, Beange H, McElduff A (1998). People with mental retardation have an increased prevalence of osteoporosis: A population study. Am J Ment Retard 103, 19-28.
4. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S et al. (1992). Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327, 1637-1642.
5. Chapuy MC, Pamphile R, Paris E, Kempf C, Schlichting M, Arnaud S et al. (2002). Combined calcium and vitamin D3 supplementationelderly women: confirmation of reversal of secondary hypreparathyroidism and hip fracture risk: The Decalyos II study. Osteoporos Int 13, 257-264.
6. Ciria M, Laiz A, Benito P (2001). Osteoporosis y grado de conocimiento de la misma en la población española [Osteoporosis and the Spanish population's awareness of it. Special issue]. In: Estudio Episer. Prevalencia e impacto de las enfermedades reumáticas en la población adulta española. Episer 2000. Madrid: Sociedad Española de Reumatología, pp. 101-123.
7. Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannebaum S (1990). A controlled trial on the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 323, 878-883.
8. Dawson-Hughes B, Harris S, Krall E, Dallal GE (1997). Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older. N Engl J Med 337, 670-676.
9. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE, Falconer G, Green CL (1995). Rates of bone loss in postmenopausal women randomly assigned to one of two dossages of vitamin D. Am J Clin Nutr 61, 1140-1145.
10. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005). Estimates of optimal vitamin D status. Osteoporos Int 16, 713-716.
11. Del Arco C, Riancho JA, Luzuriaga C, González-Macías J, Florez j (1992). Vitamin D status in children with Dowńs syndrome. J Intellect Disabil Res; 36, 251-257.
12. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J (2000). The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 11 (Suppl 6), s2-s17.
13. Gannage-Yared MH, Azoury M, Mansour I, Baddoura R, Halaby G, Naaman R (2003). Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. J Endocrinol Invest 26, 748-753.
14. Gómez Alonso C, Naves Díaz M, Rodríguez García M, Ferrer Martín JL, Cannata Andía JB (2003a) Vitamin D status and secondary hyperparathyroidism: The importance of 25-hydroxyvitamin D cut-off levels. Kidney International Suppl 85, s44.
15. Gómez Alonso C, Naves Díaz M, Rodríguez García M, Ferrer Martín JL, Cannata Andía JB (2003b) Review of The concept of vitamin D 'sufficiency and insufficiency'. Nefrologia 23 (Suppl 2), 73-77.
16. Gordon CM, DePeter K, Feldman HA, Grace E, Emans SJ (2004). Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 158, 531-537.
17. Gough H, Goggin T, Bissessar A, Baker M, Crowley M, Callaghan N (1986). A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q J Med 59, 569-577.
18. Grados F, Brazier M, Kamel S, Mathieu M, Hurtebize N, Maamer M et al. (2003). Prediction of bone mass density variation by bone remodeling markers in postmenopausal women with vitamin D insufficiency treated with calcium and vitamin D supplementation. J Clin Endocrinol Metab 88, 5175-5179.
19. Hanley DA, Josse RG (1996). Prevention and management of osteoporosis: consensus statements from de Scientific Advisory Board of Osdteoporosis Society of Canada: I. Introduction. CMAJ 155, 921-923.
20. Jaffe JS, Timell AM (2003). Prevalence of low bone density in institutionalized men with developmental disabilities. J Clin Densitom 6, 143-147.
21. La-or Ch, Boonsong O, Noppawan P, Sunee S, Rataja R (2001). Biochemical markers of turnover and response of bone mineral density to intervention in early postmenopausal women: An experience in a clinical laboratory. Clin Chem 47, 1083-1088.
22. Lewiecki EM, Watts NB, McClung MR, Petak SM, Bachrach LK, Shepherd JA et al. (2004). The International Society for Clinical Densitometry. Official Positions of the International Society for Clinical Densitometry. J Clin Endocrinol Metab 89, 3651-3655.
23. Lips P (2004). Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 89-90, 611-614.
24. MacLaughlin J, Jolick MF (1985). Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76, 1536-1538.
25. Mugica I, Ansa J, Sistiaga F, Zabalza R, Zubillaga P, Merino A et al. (2002). Digital computerized absorptiometry in the diagnosis of osteoporosis in a group of the severely mentally retarded. Nutr Hosp 17, 213-218.
26. NIH Consensus Development Panel on Osteoporosis (2001). Prevention, Diagnosis, and Therapy. Consensus Conference: From the National Institutes of Health. JAMA 285, 785-795.
27. Okabe R, Nakatsuka K, Inaba M, Miki T, Naka H, Masaki H et al. (2001). Clinical evaluation of the Elecsys beta-CrossLaps serum assay, a new assay for degradation products of type I collagen C-telopeptides. Clin Chem 47, 1410-1414.
28. Sepúlveda D, Allison DB, Gómez JE (1995). Low spinal and pelvic BMD among individuals with Down syndrome. Am J Ment Retard 100, 109-114.
29. Tangpricha V, Pearce EN, Chen TC, Holick MF (2002). Vitamin D insufficiency among free-living healthy young adults. AM J Med 112, 659-662.
30. Tyler CV, Snyder CW, Zyanski S (2000). Screening for Osteoporosis in Community - Dwelling Adults With Mental Retardation. Ment Retard 38, 316-321.
31. Van Allen MI, Fung J, Jurenka SB (1999). Health care concerns and guidelines for adults with Down syndrome. Am J Med Genet 89, 100-110.
32. Vieth R, Ladak Y, Walfish PG (2003). Age-Related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 88, 185-191.
33. Zerwekh JE (2004). The measurement of vitamin D: Analytical aspects. Ann Clin Biochem 41, 272-281.